Cartilage is an avascular and relatively tumor-resistant tissue. Work from
a number of laboratories, including our own, has demonstrated that cartilag
e is an enriched source of endogenous inhibitors of angiogenesis. In the co
urse of a study designed to identify novel cartilage-derived inhibitors of
neu capillary growth, we have purified an inhibitory protein that was ident
ified by peptide microsequencing and protein database analysis as troponin
I (TnI), TnI is a subunit of the troponin complex (troponin-C and troponin-
T being the other two), which, along with tropomyosin, is responsible for t
he calcium-dependent regulation of striated muscle contraction; independent
ly, TnI is capable of inhibiting actomyosin ATPase, Because troponin has ne
ver previously been reported to be present in cartilage, we have cloned and
expressed the cDNA of human cartilage TnI, purified this protein to appare
nt homogeneity, and demonstrated that it is a potent and specific inhibitor
of angiogenesis in vivo and in vitro, as well as of tumor metastasis in vi
vo.